{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T18:33:26Z","timestamp":1773945206497,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.urology.2004.02.029","type":"journal-article","created":{"date-parts":[[2004,8,10]],"date-time":"2004-08-10T15:55:49Z","timestamp":1092153349000},"page":"269-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: A randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"64","author":[{"given":"Vik","family":"Khullar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Ulrich","family":"Laval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hjalmar A","family":"Schi\u00f8tz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eboo","family":"Versi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2004.02.029_BIB1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1532-5415.1998.tb02469.x","article-title":"Variation in estimates of urinary incontinence prevalence in the community","volume":"46","author":"Thom","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.urology.2004.02.029_BIB2","first-page":"66","article-title":"Prevalence of urinary incontinence and associated risk factors in postmenopausal women","volume":"94","author":"Brown","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.urology.2004.02.029_BIB3","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0895-4356(00)00232-8","article-title":"A community-based epidemiological survey of female urinary incontinence","volume":"53","author":"Hannestad","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.urology.2004.02.029_BIB4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int"},{"issue":"suppl 6A","key":"10.1016\/j.urology.2004.02.029_BIB5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0090-4295(97)00599-2","article-title":"Clinical efficacy and safety of tolterodine in the treatment of overactive bladder","volume":"50","author":"Appell","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.02.029_BIB6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1464-410x.1998.00717.x","article-title":"Tolterodine, a new antimuscarinic agent","volume":"81","author":"Abrams","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2004.02.029_BIB7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s001929970003","article-title":"Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder","volume":"10","author":"Drutz","year":"1999","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.urology.2004.02.029_BIB8","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0022-5347(05)66326-4","article-title":"Tolterodine","volume":"165","author":"Malone-Lee","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2004.02.029_BIB9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0090-4295(00)01113-4","article-title":"for the Tolterodine Study Group","volume":"57","author":"Van Kerrebroeck","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.02.029_BIB10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1532-5415.1991.tb02903.x","article-title":"The quality of life in women with urinary incontinence as measured by the sickness impact profile","volume":"39","author":"Hunskaar","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.urology.2004.02.029_BIB11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1464-410X.2002.02963.x","article-title":"The effect of urinary incontinence and overactive bladder symptoms on quality of life in young women","volume":"90","author":"Van der Vaart","year":"2002","journal-title":"BJU Int"},{"issue":"suppl","key":"10.1016\/j.urology.2004.02.029_BIB12","first-page":"S608","article-title":"Health-related quality of life of patients receiving extended release tolterodine for overactive bladder","volume":"8","author":"Kelleher","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.urology.2004.02.029_BIB13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s101980100064","article-title":"Health-related quality of life of patients with overactive bladder receiving immediate-release tolterodine","volume":"2","author":"Pleil","year":"2001","journal-title":"Health Econ Prev Care (HEPAC)"},{"key":"10.1016\/j.urology.2004.02.029_BIB14","first-page":"S83","article-title":"Patient perception of bladder condition is a valid tool for evaluating the efficacy of overactive bladder therapy","volume":"13","author":"Coyne","year":"2002","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.urology.2004.02.029_BIB15","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1471-0528.1997.tb11006.x","article-title":"A new questionnaire to assess the quality of life of urinary incontinent women","volume":"104","author":"Kelleher","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.urology.2004.02.029_BIB16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1023422208910","article-title":"Multinational study of reliability and validity of the King's Health Questionnaire in patients with overactive bladder","volume":"12","author":"Reese","year":"2003","journal-title":"Qual Life Res"},{"key":"10.1016\/j.urology.2004.02.029_BIB17","first-page":"505","article-title":"Long-term health-related quality of life of patients with overactive bladder receiving tolterodine","volume":"20","author":"Kelleher","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2004.02.029_BIB18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1464-410x.1999.00004.x","article-title":"Review","volume":"83","author":"Kobelt","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2004.02.029_BIB19","unstructured":"Chakravarti IM, Laha RG, and Roy J: Handbook of Methods of Applied Statistics. New York, John Wiley & Sons, 1967, vol 1, pp 392\u2013394"},{"key":"10.1016\/j.urology.2004.02.029_BIB20","unstructured":"Abrams P, Wein A, Schussler B, et al: Recommendations of the International Scientific Committee: the evaluation and treatment of urinary incontinence, in Abrams P, Khoury S, Wein A (Eds): First International Consultation on Incontinence. Plymouth, UK, Health Publications, 1999, pp 945\u2013975"},{"key":"10.1016\/j.urology.2004.02.029_BIB21","first-page":"4","article-title":"Management of coexistent stress and urge urinary incontinence","volume":"73","author":"Karram","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.urology.2004.02.029_BIB22","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0090-4295(98)00629-3","article-title":"Tolterodine in the treatment of overactive bladder","volume":"53","author":"Larsson","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.02.029_BIB23","unstructured":"Abrams P, Kelleher CJ, Kerr LA, et al: Overactive bladder significantly affects quality of life. Am J Manag Care 6(11 suppl): S580\u2013S590, 2000"},{"key":"10.1016\/j.urology.2004.02.029_BIB24","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0090-4295(01)00986-4","article-title":"Health-related quality of life among adults with symptoms of overactive bladder","volume":"57","author":"Liberman","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.02.029_BIB25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1067\/mob.2001.108171","article-title":"Which women with stress incontinence require urodynamic evaluation?","volume":"184","author":"Weidner","year":"2001","journal-title":"Am J Obstet Gynecol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429504003085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429504003085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:39:19Z","timestamp":1758764359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429504003085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0090429504003085"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2004.02.029","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: A randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2004.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}